Adenovirus Type 4 and Type 7 Vaccine, Live

Teva Women's Health LLC🇺🇸 United States

FDA Page

Effective Date: Jul 31, 2022
Approval ID: c7d0b43c-7250-4809-8a05-fcde5862f076
Products: 0 registered
Version: 15

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use Adenovirus Type 4 and Type 7 Vaccine, Live, Oral safely and effectively. See full prescribing information for Adenovirus Type 4 and Type 7 Vaccine, Live, Oral. Adenovirus Type 4 and Type 7 Vaccine, Live, OralEnteric Coated Tablets for Oral AdministrationInitial U.S. Approval: 2011

Quick Stats

Total Products0

Labelers1

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.